News
Chameleon Biosciences Presents Poster on AAV Gene Therapy Redosing Success at ESGCT
The European Society of Gene & Cell Therapy (ESGCT) Welcomes Chameleon’s Animal Study Results Poster at its 29th Annual Conference in Edinburgh, U.K.
> Read More
Chameleon Founder Speaks at 2nd annual Gene Therapy Next Generation Vector Summit
CEO and scientist, Genine Winslow, presents Immune Suppressive AAV Based Gene Therapy for Repeat Dosing at annual event dedicated to overcoming the current immunogenicity, toxicity and manufacturability challenges facing the field by pioneering the next generation of superior delivery vectors.
> Read More
Chameleon Biosciences welcomes Alan Belicha, Ph.D.
We are pleased to announce and welcome Alan Belicha to the Chameleon team as Vice President of Business Development. In this role, Alan will guide Chameleon’s corporate development and partnering strategy, and contribute to financing efforts. We are excited to have Alan’s experience from the University of Buffalo, Mount Sinai Innovation Partners, and TTO Consulting Strategic available to our team,…
> Read More
Chameleon Founder Speaks at 5th annual Gene Therapy for Rare Disorders Conference
Immunology and gene therapy CEO and scientist, Genine Winslow, presents innovative vector modifications at industry summit. Learn more about the conference and see the press release.
> Read MorePress Releases
- July 19, 2022
EIN Presswire: Chameleon Founder Speaks at 2nd annual Gene Therapy Next Generation Vector Summit /
CEO and scientist presents Immune Suppressive AAV Based Gene Therapy for Repeat Dosing - April 29, 2022
EIN Presswire, MENAFN
Science News Today: CEO/CFO Interviews Chameleon Biosciences, Inc. Founder CEO, Genine Winslow on how they are Expanding AAV Gene Therapies with EVADER™ - March 9, 2022
AP News, Benzinga, Yahoo! Finance:
Chameleon Biosciences Founder to Speak at Gene Therapy Next Generation Vector Summit 2022 in Boston - Jan 5, 2022
AP News, Big News Network, Digital Journal, Yahoo! Finance:
Chameleon Biosciences Appoints Silicon Valley Scientist and Entrepreneur, Dr. Thomas Chalberg, to Board Position
What Others Are Saying...
- Nov 8, 2022
BioPharma Reporter:
Chameleon's immunomodulatory technology wins biotech breakthrough award - May 9, 2022
Cell and Gene Therapy Insights:
Overcoming the immune-related shortfalls of AAV - May 3, 2022
Bay Area INNO:
Chameleon Biosciences is developing a better way to treat rare genetic diseases
- Apr 25, 2022
CEO/CFO Magazine:
Expanding AAV Gene Therapies with EVADER™ - Mar-Apr 2022
Bay Area INNO:
Inno Madness
Apr 20, Apr 14, Apr 6, Mar 30, Mar 29, Mar 1 - Apr 14, 2022
BioSpace:
CureDuchenne is Filling the Therapeutic Pipeline with Next Generation DMD Treatments - Apr 14, 2022
eHealth Radio Network:
The Latest in Gene Therapy with Genine Winslow - Feb 15, 2022
BioSpace:
Chameleon's Cloaking Technology Makes Multi-Dose Gene Therapy a Reality - Feb 2, 2022
Bizwomen: In Her Own Words:
Scientist Genine Winslow - Jan 5, 2022
BioWorld:
Appointments & Advancements
Startseite Tiroler Tageszeitung Online Nachrichten Seitens Jetzt!
Mit Book of Ra hat Novoline einen der beliebtesten Spielautomaten weltweit vom Portfolio. Nahezu die meisten Novoline-Slots lassen gegenseitig im Casino gemeinsam kostenlos ohne Anmeldung spielen. Mit einen Klassikern wie Sizzling Hot oder Lucky Lady’s Charm zählt Novoline vorwiegend im rahmen (von) deutschen Spielern abgeschlossen den beliebtesten Providern. Das Spieleangebot welcher Online Casinos ist natürlich mit dem von seiten klassischen…
> Read More